Moderna’s (MRNA.US) announced that its experimental vaccine for coronavirus showed promise in early trials. Biotech company announced that it's early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all 45 participants. Vaccine also kept the virus that causes Covid-19 from replicating in the lungs of mice. Moderna has developed the first experimental coronavirus medicine, but an approved treatment is more than a year away.
Moderna’s (MRNA.US) stock rocketed over 28% in pre market trading. Source: xStation5
S&P500 (US500) - Futures contracts tied to the major U.S. stock indexes rose sharply Monday, as news from a Moderna trial stoked optimism about a potential coronavirus vaccine. Source: xStation5